European Journal of Medical Genetics
Scope & Guideline
Unlocking Genetic Secrets for Better Health Outcomes
Introduction
Aims and Scopes
- Genetic Disorders and Syndromes:
The journal extensively covers a wide range of genetic disorders, including rare diseases, syndromes, and chromosomal abnormalities, providing insights into their clinical presentations, genetic underpinnings, and management strategies. - Clinical Genetics and Genomic Medicine:
A significant focus is placed on clinical genetics, including the application of genomic technologies such as next-generation sequencing (NGS) in diagnosing genetic conditions, evaluating variants of uncertain significance, and exploring genotype-phenotype correlations. - Patient-Centered Research and Healthcare:
Research that emphasizes patient experiences, clinical outcomes, and quality of life for individuals with genetic disorders is a core area, highlighting the importance of patient perspectives in genetic counseling and treatment. - Ethics and Policy in Genetic Testing:
The journal addresses ethical considerations in genetic testing, including informed consent, disclosure of genetic risks, and the implications of genetic information on family dynamics and healthcare practices. - Emerging Genetic Technologies and Therapies:
The European Journal of Medical Genetics also explores novel genetic therapies and diagnostic technologies, emphasizing their potential impact on patient care and the future of personalized medicine.
Trending and Emerging
- Integration of Genomic Technologies:
There is a growing emphasis on the application of advanced genomic technologies, such as NGS and whole-genome sequencing, in clinical settings to improve diagnostic accuracy and facilitate personalized treatment plans. - Focus on Rare Genetic Disorders:
An increasing number of studies are dedicated to rare genetic disorders, which often lack sufficient research and understanding, thereby addressing a critical gap in the field of medical genetics. - Patient-Centric Research:
Research that prioritizes patient perspectives, experiences, and outcomes is on the rise, reflecting a shift towards more holistic approaches in managing genetic conditions and enhancing the quality of care. - Ethical and Social Implications of Genetic Testing:
As genetic testing becomes more prevalent, there is an emerging focus on the ethical, social, and psychological implications of test results, including issues related to consent, privacy, and familial relationships. - Telemedicine and Remote Genetic Counseling:
The COVID-19 pandemic has accelerated the integration of telemedicine in genetic counseling, leading to increased research on its effectiveness, accessibility, and impact on patient engagement and satisfaction.
Declining or Waning
- Traditional Cytogenetic Techniques:
There is a noticeable decrease in publications focusing solely on traditional cytogenetic methods, such as karyotyping and FISH, as newer genomic technologies like whole-exome sequencing and NGS have become the standard for genetic analysis. - Generalized Genetic Counseling Approaches:
Research centered on generalized or traditional genetic counseling methods is waning, with a shift towards more personalized and tailored approaches that consider individual patient circumstances and preferences. - Focus on Common Genetic Disorders:
The journal's emphasis appears to be moving away from common genetic disorders, such as cystic fibrosis or sickle cell disease, towards rare and complex genetic conditions, reflecting a broader interest in under-researched areas. - Basic Genetic Mechanisms:
There is a decline in studies that primarily discuss basic genetic mechanisms without clinical implications, as the journal increasingly prioritizes research that directly informs clinical practice and patient outcomes.
Similar Journals
CLINICAL GENETICS
Innovating solutions for genetic challenges.CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.
PRENATAL DIAGNOSIS
Transforming Insights into Clinical PracticePRENATAL DIAGNOSIS is an esteemed journal dedicated to the fields of genetics and obstetrics, published by Wiley. With an ISSN of 0197-3851 and E-ISSN of 1097-0223, this journal has been a leading platform for the dissemination of pioneering research since its inception in 1980. Operating from its base in the United Kingdom, PRENATAL DIAGNOSIS has achieved notable recognition, attaining a Q2 category in Genetics (Clinical) and a prestigious Q1 category in Obstetrics and Gynecology as of 2023. It ranks 41st out of 209 in Obstetrics and Gynecology and 40th out of 99 in Clinical Genetics according to Scopus, placing it in the 80th and 60th percentiles, respectively. This journal provides a critical resource for researchers, healthcare professionals, and students who are focused on advancing the science of prenatal diagnosis and its application in clinical practice. While not an open access journal, the content is pivotal for those aiming to engage with the most current findings and methodologies in prenatal care. As it looks toward 2024 and beyond, PRENATAL DIAGNOSIS continues to strive for excellence in fostering breakthroughs that impact maternal and fetal health.
JOURNAL OF HUMAN GENETICS
Pioneering Insights into Genetic DisordersWelcome to the Journal of Human Genetics, a premier publication in the field of human genetics, published by SpringerNature. With a commitment to sharing groundbreaking research, this journal has been at the forefront of genetic studies since its establishment in 1961, converging its focus in 1996 and continuing to evolve through 2024. It holds a respected Q2 ranking in both the Genetics and Clinical Genetics categories, reflecting its significant contribution to the scientific community. With a notable Scopus ranking of 23rd out of 99 in Clinical Genetics and 95th out of 347 in Genetics, the journal offers a platform for high-impact research that informs clinical practices and advances the understanding of genetic disorders. Operating under an open-access model, it ensures that findings are readily accessible to researchers, professionals, and students worldwide. Join us in exploring the complexities of human genetics and contribute to the ongoing discourse in this dynamic field.
npj Genomic Medicine
Exploring the Frontiers of Genetics and Medicinenpj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.
Journal of Pediatric Genetics
Bridging Research and Practice in Pediatric GeneticsJournal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.
Annual Review of Genomics and Human Genetics
Connecting Research and Discovery in Human GeneticsAnnual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.
CYTOGENETIC AND GENOME RESEARCH
Fostering innovation in cytogenetics and molecular biology.CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.
GENETICS IN MEDICINE
Pioneering Insights for Healthcare ProfessionalsGENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.
Medizinische Genetik
Advancing the Frontiers of Medical Genetics.Medizinische Genetik is a distinguished academic journal, published by Walter de Gruyter GmbH, that serves the field of medical genetics, offering insights and developments in both clinical and laboratory settings. Since its inception in 1994, the journal has provided a platform for researchers and professionals to disseminate their findings, contributing significantly to scientific discourse in genetics. Although currently listed in the Q4 category for both Genetics and Clinical Genetics according to the 2023 rankings, it remains a vital resource for those looking to understand the evolving landscape of medical genetics. This peer-reviewed journal is accessible through various academic platforms, fostering collaboration and knowledge sharing among academics, clinicians, and students alike. As the journal converges towards 2024, it continues to solidify its role in enhancing the understanding of genetic disorders and innovations in genetic research.
Egyptian Journal of Medical Human Genetics
Pioneering research in human genetics for global impact.The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.